Reaction
Basfi Score Increased reporting signals
As of the last recalculation, Basfi Score Increased appears in 39 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is CERTOLIZUMAB PEGOL (PRR 1,200.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Certolizumab Pegol | 34 | 1,200.9 | 1,201.2 |
| Bimekizumab | 4 | 111.6 | 111.6 |